Literature DB >> 31810023

Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 5-year outcomes of the HYPITAT II trial.

Eva F Zwertbroek1, Julia Zwertbroek2, Kim Broekhuijsen3, Maureen T M Franssen2, Wessel Ganzevoort4, Josje Langenveld5, Ben W J Mol6, Marielle van Pampus7, Sicco Scherjon2, Anneloes L van Baar8, Henk Groen9.   

Abstract

OBJECTIVE: To compare effects of immediate delivery vs expectant monitoring on neurodevelopmental and behavioral outcomes at 5 years of age in offspring of women with mild late preterm hypertensive disorders. STUDY
DESIGN: We studied children born during the HYPITAT-II trial, in which 704 women with a hypertensive disorder between 34 and 37 weeks of gestation were randomized to immediate delivery or expectant monitoring. Participating women were asked to complete the Ages and Stages Questionnaire (ASQ) for developmental outcome and the Child Behavior Checklist (CBCL) for behavioral problems when their child was 5 years old. Outcomes were dichotomized and analyzed by logistic regression analysis. We also assessed factors influencing development and behavior at both 2 and 5 years after a hypertensive pregnancy.
RESULTS: Five years after the original study 322(46%) women were contacted for follow-up, of whom 148 (46%) responded. In the delivery group 22%(n = 14/65) of the children had an abnormal ASQ score compared to 21% (n = 13/62) in the expectant monitoring group (p = 0.9). Abnormal CBCL-scores were found in 19% (n = 14/72) of the children in the delivery group versus in 27% (n = 20/75) in the expectant monitoring group (p = 0.3). The main predictor of development and behavior at 2 and 5 years was fetal growth restriction (for abnormal development OR 2.1, CI 1.0-4.4; for behavior problems OR 2.2, CI 1.1-5.5). Higher maternal education decreased abnormal behavior outcomes (OR 0.5, CI 0.2-0.9) and a similar tendency was observed for developmental problems (OR 0.6, CI 0.3 - 1.1).
CONCLUSION: We did not find different developmental and behavior outcomes at 5 years of age between a management policy of immediate delivery and expectant management in preterm hypertensive disorders. The increased risk of developmental delay at 2 years of age after immediate delivery, we found in the 2 year follow up study, did not persist at 5 years of age.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ages and stages questionnaire; Behavior; Child behavior checklist; Chronic hypertension; Follow-up; Gestational hypertension; HYPITAT II trial; Hypertensive disorder of pregnancy; Long term outcome; Neurodevelopment; Preeclampsia; Superimposed preeclampsia

Year:  2019        PMID: 31810023     DOI: 10.1016/j.ejogrb.2019.11.001

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Health Outcomes Associated With Clinician-initiated Delivery for Hypertensive Disorders at 34-38 Weeks' Gestation.

Authors:  David A Savitz; Valery A Danilack; Jerson Cochancela; Brenna L Hughes; Dwight J Rouse; Roee Gutmann
Journal:  Epidemiology       Date:  2022-03-01       Impact factor: 4.822

Review 2.  A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics).

Authors:  Liona C Poon; Laura A Magee; Stefan Verlohren; Andrew Shennan; Peter von Dadelszen; Eyal Sheiner; Eran Hadar; Gerard Visser; Fabricio Da Silva Costa; Anil Kapur; Fionnuala McAuliffe; Amala Nazareth; Muna Tahlak; Anne B Kihara; Hema Divakar; H David McIntyre; Vincenzo Berghella; Huixia Yang; Roberto Romero; Kypros H Nicolaides; Nir Melamed; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-07       Impact factor: 4.447

3.  Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX).

Authors:  Rachael Hunter; Alice Beardmore-Gray; Melanie Greenland; Louise Linsell; Edmund Juszczak; Pollyanna Hardy; Anna Placzek; Andrew Shennan; Neil Marlow; Lucy C Chappell
Journal:  Pharmacoecon Open       Date:  2022-07-21

4.  Two-year follow-up of infant and maternal outcomes after planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): A randomised controlled trial.

Authors:  Alice Beardmore-Gray; Melanie Greenland; Louise Linsell; Edmund Juszczak; Pollyanna Hardy; Anna Placzek; Rachael Hunter; Jenie Sparkes; Marcus Green; Andrew Shennan; Neil Marlow; Lucy C Chappell
Journal:  BJOG       Date:  2022-05-12       Impact factor: 7.331

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.